Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The NEVOLUTION Study: An Open Label, Single-arm, Phase II Study of Neoadjuvant Nivolumab in Locally Advanced Upper Tract Urothelial Carcinoma

NCT05160285 is registered in ClinicalTrials.gov with YULISU as lead sponsor.

NCT NCT05160285
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05160285 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The NEVOLUTION Study: An Open Label, Single-arm, Phase II Study of Neoadjuvant Nivolumab in Locally Advanced Upper Tract Urothelial Carcinoma
Lead sponsor
YULISU
Phase
Phase 2
Overall status
Unknown status
Start date
December 25, 2020
Completion date
December 30, 2024
Enrollment
29 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

upper urinary tract urothelial carcinoma